In the 2010 version of Chinese guidelines on the diagnosis and treatment of primary lung cancer, tumor markers for lung cancer were optional in qualified hospitals and only four tumor markers, CEA, Cyfra21‐1, NSE, and SCC were recommended only as references. This evidence concerns the gene ENO2 and neoplasm.